{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:36:30Z","timestamp":1782840990131,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["94-01-101-27529"],"award-info":[{"award-number":["94-01-101-27529"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00403-018-1817-9","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:58:56Z","timestamp":1518051536000},"page":"255-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid"],"prefix":"10.1007","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1020-8895","authenticated-orcid":false,"given":"Maryam","family":"Daneshpazhooh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghiasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahideh","family":"Lajevardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafise","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Balighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Teimourpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahide","family":"Saeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheyda","family":"Chams-Davatchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"1817_CR1","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/j.1365-2133.1997.tb03654.x","volume":"136","author":"P Bernard","year":"1997","unstructured":"Bernard P, Bedane C, Bonnetblanc JM (1997) Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients. Br J Dermatol 136:694\u2013698","journal-title":"Br J Dermatol"},{"key":"1817_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","volume":"110","author":"LS Chan","year":"1998","unstructured":"Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, Wojnarowska F, Steven SR, Chen M, Fairley JA, Woudley DT, Miller SD, Gordon KB (1998) Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 110:103\u2013109","journal-title":"J Invest Dermatol"},{"key":"1817_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-4632.2011.04946.x","volume":"51","author":"M Daneshpazhooh","year":"2012","unstructured":"Daneshpazhooh M, Chams-Davatchi C, Payandemehr P, Nassiri S, Valikhani M, Safai-Naraghi Z (2012) Spectrum of autoimmune bullous diseases in Iran: a 10-year review. Int J Dermatol 51:35\u201341","journal-title":"Int J Dermatol"},{"key":"1817_CR4","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1038\/jid.2011.180","volume":"131","author":"G Zenzo Di","year":"2011","unstructured":"Di Zenzo G, Thoma-Uszynski S, Calabresi V, Fontao L, Hofmann SC, Lacour JP, Sera F, Bruckner-Tuderman L, Zambruno G, Borradori L, Hertl M (2011) Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study. J Invest Dermatol 131:2271\u20132280","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1817_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjd.15114","volume":"177","author":"T Hashimoto","year":"2017","unstructured":"Hashimoto T, Ohzono A, Teye K et al (2017) Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid. Br J Dermatol 177(1):141\u2013151","journal-title":"Br J Dermatol"},{"key":"1817_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","volume":"49","author":"N Ishiura","year":"2008","unstructured":"Ishiura N, Fujimoto M, Watanabe R, Nakashima H, Kuwano Y, Yazawa N, Echigo T, Okochi H, Tamaki K (2008) Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 49:153\u2013161","journal-title":"J Dermatol Sci"},{"key":"1817_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5021\/ad.2012.24.1.45","volume":"24","author":"EH Lee","year":"2012","unstructured":"Lee EH, Kim YH, Kim S, Kim SE, Kim SC (2012) Usefulness of enzyme-linked immunosorbent assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid. Ann Dermatol 24:45\u201355","journal-title":"Ann Dermatol"},{"key":"1817_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000337545","volume":"224","author":"L Sache-de Peufeilhoux Le","year":"2012","unstructured":"Le Sache-de Peufeilhoux L, Ingen-Housz-Oro S, Hue S, Sbidian E, Valeyrie-Allanore L, Ortonne N, Roujeau JC, Wolkenstein P, Chosidow O, Andr\u00e9 C (2012) The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid. Dermatology 224:154\u2013159","journal-title":"Dermatology"},{"key":"1817_CR9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000362717","volume":"229","author":"C Levy-Sitbon","year":"2014","unstructured":"Levy-Sitbon C, Barbe C, Plee J, Goeldel AL, Antonicelli F, Reguia\u00ef Z, Jolly D, Grange F, Bernard P (2014) Assessment of bullous pemphigoid disease area index during treatment: a prospective study of 30 patients. Dermatology 229:116\u2013122","journal-title":"Dermatology"},{"key":"1817_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","volume":"66","author":"DF Murrell","year":"2012","unstructured":"Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T, Caux F, Marinovic B, Sinha AA, Hertl M, Bernard P, Sirois D, Cianchini G, Fairley JA, Jonkman MF, Pandya AG, Rubenstein D, Zillikens D, Payne AS, Woodley D, Zambruno G, Aoki V, Pincelli C, Diaz L, Hall RP, Meurer M, Mascaro JM Jr, Schmidt E, Shimizu H, Zone J, Swerlick R, Mimouni D, Culton D, Lipozencic J, Bince B, Grando SA, Bystryn JC, Werth VP (2012) Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol 66:479\u2013485","journal-title":"J Am Acad Dermatol"},{"key":"1817_CR11","doi-asserted-by":"publisher","first-page":"854795","DOI":"10.1155\/2012\/854795","volume":"2012","author":"A Patsatsi","year":"2012","unstructured":"Patsatsi A, Kyriakou A, Pavlitou-Tsiontsi A, Giannakou A, Sotiriadis D (2012) Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid. Clin Dev Immunol 2012:854795","journal-title":"Clin Dev Immunol"},{"key":"1817_CR12","first-page":"4","volume":"17","author":"M Pfutze","year":"2007","unstructured":"Pfutze M, Niedermeier A, Hertl M, Eming R (2007) Introducing a novel autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus. Eur J Dermatol 17:4\u201311","journal-title":"Eur J Dermatol"},{"key":"1817_CR13","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","volume":"134","author":"L Vaillant","year":"1998","unstructured":"Vaillant L, Bernard P, Joly P, Prost C, Labeille B, Bedane C, Arbeille B, Thomine E, Bertrand P, Lok C, Roujeau JC (1998) Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol 134:1075\u20131080","journal-title":"Arch Dermatol"},{"key":"1817_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","volume":"153","author":"N Beek van","year":"2017","unstructured":"van Beek N, L\u00fcttmann N, Huebner F, Recke A, Karl I, Schulze FS, Zillikens D, Schmidt E (2017) Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity. JAMA Dermatol 153:30\u201338","journal-title":"JAMA Dermatol"},{"key":"1817_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2340\/00015555-2473","volume":"96","author":"A Wijayanti","year":"2017","unstructured":"Wijayanti A, Zhao CY, Boettiger D, Chiang YZ, Ishii N, Hashimoto T, Murrell DF (2017) The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for bullous pemphigoid: which one to use? Acta Derm Venereol 96:24\u201331","journal-title":"Acta Derm Venereol"},{"key":"1817_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/1346-8138.12711","volume":"42","author":"CY Zhao","year":"2015","unstructured":"Zhao CY, Murrell DF (2015) Outcome measures for autoimmune blistering diseases. J Dermatol 42:31\u201336","journal-title":"J Dermatol"},{"key":"1817_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/1346-8138.13051","volume":"43","author":"XP Zhou","year":"2016","unstructured":"Zhou XP, Liu B, Xu Q, Yang Y, He CX, Zuo YG, Liu YH (2016) Serum levels of immunoglobulins G1 and G4 targeting the non-collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis. J Dermatol 43:141\u2013148","journal-title":"J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-018-1817-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1817-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1817-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T20:33:55Z","timestamp":1549571635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-018-1817-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1817"],"URL":"https:\/\/doi.org\/10.1007\/s00403-018-1817-9","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"To the authors\u2019 knowledge, no conflict of interest, financial or other exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The institutional review board of Tehran University of Medical Sciences has approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients gave informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}